Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

The Medicines Company

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of The Medicines Company's 2013 cardiovasular sales performance.

The Medicines Company

Novartis picks up inclisiran after completion of MedCo acquisition

Novartis picks up inclisiran after completion of MedCo acquisition If approved could become blockbuster cholesterol treatment. Novartis has added potential blockbuster cholesterol treatment inclisiran to its pipeline following the completion of its $9.7bn acquisition of The Medicines Company. . ... 2021. “Acquiring

Novartis acquires The Medicines Company for $9.7bn following takeover rumours

Novartis acquires The Medicines Company for $9.7bn following takeover rumours MedCo's cholesterol lowering inclisiran main attraction in planned acquisition. Last week, The Medicines Company surged on reported rumours that Novartis was planning to acquire it – reports that have now been ... The prospect of bringing inclisiran to

The Medicines Company surges on rumours of Novartis takeover

The Medicines Company surges on rumours of Novartis takeover Shares in The Medicines Company have leapt on rumours that Novartis is eyeing a takeover of the company and its promising new cardiovascular drug inclisiran. ... Novartis – or indeed another party – may be prepared to pay for the company.

TMC preps filings for inclisiran after final phase 3 trials hit the mark

TMC preps filings for inclisiran after final phase 3 trials hit the mark Less frequent dosing schedules could prove an advantage over rivals. The Medicines Company has positive top-line data from the last of its phase 3 trials of inclisiran, setting up regulatory ... The ORION-9 and ORION-10 data will be reported in full at

TMC’s full data for inclisiran impresses at ESC

TMC’s full data for inclisiran impresses at ESC Marketing applications expected before end of year. The Medicine’s Company has unveiled the impressive detailed results of its LDL-C lowering drug inclisiran at the ESC 2019, setting up a ... By lowering LDL levels, or ‘bad’ cholesterol, the

[ Previous 5 results ] 1 2 3 4 5 6 7 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

Menopause-thumbnail.png
Breaking the silence: It’s time to talk about the menopause
Using findings from our latest opinion poll, Vicki Newlove outlines why the hidden landscape of menopause may finally be starting to change....
Committing time to making meaningful connections - top 5 tips
Read the second blog of the series looking at key barriers to effective patient engagement in pharma...
News:
Senior Analytics Specialist joins Research Partnership...